Qsemble Capital Management LP Buys New Holdings in Agilent Technologies, Inc. $A

Qsemble Capital Management LP bought a new stake in Agilent Technologies, Inc. (NYSE:A) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 84,958 shares of the medical research company’s stock, valued at approximately $11,560,000. Agilent Technologies comprises about 1.0% of Qsemble Capital Management LP’s portfolio, making the stock its 11th biggest holding.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Stephens Inc. AR boosted its holdings in Agilent Technologies by 4.9% in the fourth quarter. Stephens Inc. AR now owns 4,924 shares of the medical research company’s stock valued at $670,000 after acquiring an additional 231 shares during the last quarter. AlphaCore Capital LLC acquired a new position in Agilent Technologies in the fourth quarter valued at $291,000. DNB Asset Management AS boosted its holdings in Agilent Technologies by 6.2% in the fourth quarter. DNB Asset Management AS now owns 58,091 shares of the medical research company’s stock valued at $7,904,000 after acquiring an additional 3,371 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in Agilent Technologies by 452.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 21,981 shares of the medical research company’s stock valued at $2,991,000 after acquiring an additional 18,004 shares during the last quarter. Finally, Phoenix Financial Ltd. boosted its holdings in Agilent Technologies by 4.3% in the fourth quarter. Phoenix Financial Ltd. now owns 4,795 shares of the medical research company’s stock valued at $652,000 after acquiring an additional 198 shares during the last quarter.

Agilent Technologies Trading Down 1.4%

Shares of A opened at $111.69 on Friday. The stock’s 50-day moving average is $115.06 and its two-hundred day moving average is $130.68. The stock has a market cap of $31.56 billion, a PE ratio of 24.66, a P/E/G ratio of 2.38 and a beta of 1.22. Agilent Technologies, Inc. has a 12 month low of $107.07 and a 12 month high of $160.27. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the prior year, the firm earned $1.31 EPS. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 5.95 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on A shares. HSBC initiated coverage on Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price on the stock. Wells Fargo & Company reduced their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. TD Cowen reduced their price objective on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, Morgan Stanley reduced their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.